Daniel Marsh

Daniel Marsh

Senior Markets Analyst

Daniel Marsh is a senior markets analyst at StockTi with over 12 years of experience covering U.S. and global equity markets. He holds a CFA charter and previously worked as an equity research associate at a major Wall Street firm. Daniel specializes in macroeconomic analysis, market trends, and cross-sector investment themes. His work focuses on translating complex market data into actionable insights for individual and institutional investors.

Markets, Economy, Analysis 4,604 articles

Articles by Daniel Marsh

DroneShield Stock Surges on Key Executive Appointment Ahead of Financial Results
Markets

DroneShield Stock Surges on Key Executive Appointment Ahead of Financial Results

DroneShield shares climbed 7.3% following the appointment of former Thales Australia executive Michael Powell as Chief Operating Officer. Investors now await the company's FY2025 results, scheduled for release on February 19.

EWA
CSL Leadership Transition Weighs on ASX Amid Tech Rebound
Markets

CSL Leadership Transition Weighs on ASX Amid Tech Rebound

CSL shares fell nearly 5% following CEO Paul McKenzie's unexpected retirement, overshadowing a broader market recovery led by technology stocks. The S&P/ASX 200 closed essentially flat at 8,867.4.

CSL NVDA XLK
Suncorp Leads Insurance Sector Sell-Off Amid AI Disruption Fears
Markets

Suncorp Leads Insurance Sector Sell-Off Amid AI Disruption Fears

Suncorp shares dropped 4.24% as investor concerns over ChatGPT-powered insurance applications sparked a sector-wide decline. The sell-off comes ahead of the company's half-year results on February 18.

SUNC
NAB Shares Steady Ahead of Quarterly Update Amid Shifting Rate Expectations
Markets

NAB Shares Steady Ahead of Quarterly Update Amid Shifting Rate Expectations

National Australia Bank shares closed flat at A$43.98 in a volatile session as investors await next week's trading update. The bank will raise variable home loan rates following the RBA's latest hike.

EWA
CSL CEO Steps Down Ahead of Earnings, Interim Leader Named as Shares Slide
Markets

CSL CEO Steps Down Ahead of Earnings, Interim Leader Named as Shares Slide

CSL announced CEO Paul McKenzie's retirement, with Gordon Naylor appointed interim chief effective February 11. The leadership change comes one day before the company's half-year results.

CSL
BHP Gains on ASX as Copper Expansion and Port Reopening Draw Investor Attention Ahead of Earnings
Markets

BHP Gains on ASX as Copper Expansion and Port Reopening Draw Investor Attention Ahead of Earnings

BHP shares advanced 1.1% to A$50.26, with focus on its copper investment plans and the reopening of key iron ore ports. The miner reports half-year results on February 17.

BHP RIO
Westpac Shares Slide on CIO Retirement Announcement Ahead of Key Banking Results
Markets

Westpac Shares Slide on CIO Retirement Announcement Ahead of Key Banking Results

Westpac shares declined 1.8% following news that Chief Information Officer Scott Collary will retire this year. The broader banking sector softened ahead of Commonwealth Bank's earnings report, while consumer sentiment hit a 10-month low.

CBAUF
AI Energy Startup Tem Secures $75M, Hasbro Rally Analyzed, Micro-Cap Plummets
Markets

AI Energy Startup Tem Secures $75M, Hasbro Rally Analyzed, Micro-Cap Plummets

London's Tem raises $75M in Series B funding to expand its AI-driven electricity platform. Hasbro stock shows a 69% rally but DCF suggests undervaluation, while Finaxo Environnement drops sharply in thin trading.

HAS
Linde Shares Gain as Analysts Revise Targets Amid Strong Backlog Outlook
Markets

Linde Shares Gain as Analysts Revise Targets Amid Strong Backlog Outlook

Linde shares rose 1.8% to $456.34 after analysts adjusted price targets, while the company projects robust 2026 earnings and maintains a record $10 billion project backlog.

LIN APD
Merck Shares Drop on Insider Sale, Investors Await Key FDA Decision
Markets

Merck Shares Drop on Insider Sale, Investors Await Key FDA Decision

Merck & Co. stock fell 3.5% amid an executive share sale and underperformance versus a broader market rally. Traders are focused on an upcoming FDA ruling for Keytruda's ovarian cancer expansion.

MRK AMGN XLV
Johnson & Johnson Shares Dip in Extended Trading Amid Healthcare Sector Weakness
Markets

Johnson & Johnson Shares Dip in Extended Trading Amid Healthcare Sector Weakness

Johnson & Johnson stock declined 0.6% in after-hours trading Monday as healthcare stocks underperformed the broader market. The company faces ongoing talc litigation and will present at an industry conference next month.

JNJ SPY QQQ XLV
Bank of America Shares Dip Ahead of Key Economic Data, CEO Remarks
Markets

Bank of America Shares Dip Ahead of Key Economic Data, CEO Remarks

Bank of America stock edged lower in after-hours trading as investors await critical U.S. jobs and inflation reports. CEO Brian Moynihan is scheduled to speak Tuesday.

BAC JPM XLF